These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors. Ma CC; Liu ZP Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599 [TBL] [Abstract][Full Text] [Related]
3. A novel hybrid of 3-benzyl coumarin seco-B-ring derivative and phenylsulfonylfuroxan induces apoptosis and autophagy in non-small-cell lung cancer. Dong M; Ye T; Bi Y; Wang Q; Kuerban K; Li J; Feng M; Wang K; Chen Y; Ye L Phytomedicine; 2019 Jan; 52():79-88. PubMed ID: 30599915 [TBL] [Abstract][Full Text] [Related]
4. Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo. Yao D; Pan D; Zhen Y; Huang J; Wang J; Zhang J; He Z Pharmacol Res; 2020 Feb; 152():104605. PubMed ID: 31863866 [TBL] [Abstract][Full Text] [Related]
5. Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling. Liu H; Wang Y; Sharma A; Mao R; Jiang N; Dun B; She JX Anticancer Drugs; 2015 Jul; 26(6):667-77. PubMed ID: 25811964 [TBL] [Abstract][Full Text] [Related]
6. A review of coumarin derivatives in pharmacotherapy of breast cancer. Musa MA; Cooperwood JS; Khan MO Curr Med Chem; 2008; 15(26):2664-79. PubMed ID: 18991629 [TBL] [Abstract][Full Text] [Related]
7. Triphenylethylene-Coumarin Hybrid TCH-5c Suppresses Tumorigenic Progression in Breast Cancer Mainly Through the Inhibition of Angiogenesis. Cui N; Lin DD; Shen Y; Shi JG; Wang B; Zhao MZ; Zheng L; Chen H; Shi JH Anticancer Agents Med Chem; 2019; 19(10):1253-1261. PubMed ID: 30947677 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action. Elshemy HAH; Zaki MA Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents. Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772 [TBL] [Abstract][Full Text] [Related]
10. Antiproliferative Effect of N-Heterocyclo-Coumarin Derivatives against Multidrug-Resistant Cells. Wada K; Goto M; Lee KH; Yamashita H Chem Pharm Bull (Tokyo); 2023; 71(1):52-57. PubMed ID: 36596512 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and biological characterization of a novel anti-aromatase coumarin derivative. Chen S; Cho M; Karlsberg K; Zhou D; Yuan YC J Biol Chem; 2004 Nov; 279(46):48071-8. PubMed ID: 15358790 [TBL] [Abstract][Full Text] [Related]
12. Synthetic Mono/di-halogenated Coumarin Derivatives and Their Anticancer Properties. Kasumbwe K; Venugopala KN; Mohanlall V; Odhav B Anticancer Agents Med Chem; 2017; 17(2):276-285. PubMed ID: 27671300 [TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents. Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768 [TBL] [Abstract][Full Text] [Related]
14. Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview. Ratre P; Kulkarni S; Das S; Liang C; Mishra PK; Thareja S Med Oncol; 2022 Dec; 40(1):41. PubMed ID: 36471176 [TBL] [Abstract][Full Text] [Related]
15. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif. Dlugosz A; Gach-Janczak K; Szymanski J; Deredas D; Krawczyk H; Janecki T; Janecka A Anticancer Agents Med Chem; 2018; 18(3):450-457. PubMed ID: 28933263 [TBL] [Abstract][Full Text] [Related]
16. Recent developments of C-4 substituted coumarin derivatives as anticancer agents. Dandriyal J; Singla R; Kumar M; Jaitak V Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469 [TBL] [Abstract][Full Text] [Related]
17. Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants. Kurtanović N; Tomašević N; Matić S; Mitrović MM; Kostić DA; Sabatino M; Antonini L; Ragno R; Mladenović M Eur J Med Chem; 2022 Jan; 227():113869. PubMed ID: 34710747 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids. Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370 [TBL] [Abstract][Full Text] [Related]
19. Coumarin-Fatty Acid Conjugates as Potential ERα/AKT-1 Antagonists for ER Positive Breast Cancer. Selvaraj J; John JBA; Joghee NM; Antony J; Wadhwani A; Natarajan J Anticancer Agents Med Chem; 2020; 20(4):437-449. PubMed ID: 31746305 [TBL] [Abstract][Full Text] [Related]
20. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells. Kamal A; Lakshma Nayak V; Nagesh N; Vishnuvardhan MV; Subba Reddy NV Bioorg Chem; 2016 Jun; 66():124-31. PubMed ID: 27149364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]